Synthetic Engineering of Enhanced Fitness and Adhesion Properties in Probiotics for the treatment of Inflammatory Bowel Disease.

Potential of Parasite Products to Suppress Inflammatory Bowel Disease.

Development of a Fecal Microbiota Transplant Mouse Model for Ulcerative Colitis to Identify Pro-and Anti-inflammatory Bacteria.

A Novel Mouse Model to Study the Molecular Basis of Chronic Inflammation in Inflammatory Bowel Disease.

Treating Inflammatory Bowel Disease by Enhancing HNF-4a Activity.

Interface Between Antigen-Presenting Cells, Lympahtics, and the Expansion of Adipose Tissue in Inflammatory Intestinal Disease.

Identification of Microbial Triggers of Colitis in Genetically Relevant, Transmissible Mouse Model.

Bioengineering Bacterially Derived Immunomodulants: A Novel Therapeutic Approach to IBD.

Harnessing Immuno-nanotechnology for Therapy of Inflammatory Bowel Disease.

Epigenetic Control of Intestinal Inflammation.